Comply with Regulations, FDA Warns Allergan and Ideal Implant
The US Food and Drug Administration (FDA) issued warning letters recently to two breast implant manufacturers for failure to comply with various regulatory requirements.
The US Food and Drug Administration (FDA) issued warning letters recently to two breast implant manufacturers for failure to comply with various regulatory requirements.